Published in J Biol Chem on October 01, 1953
Phospholipids. 3. On the chromatographic separation of glycerophospholipids. Biochem J (1955) 4.96
Is hemoglobin an essential structural component of human erythrocyte membranes? J Clin Invest (1963) 4.21
Phospholipids. IV. On the composition of hen's egg phospholipids. Biochem J (1957) 3.11
The structure of the naturally occurring phosphoglycerides. 4. Action of cabbage-leaf phospholipase D on ovolecithin and related substances. Biochem J (1958) 2.75
Separation and composition of the phospholipids of ox heart. Biochem J (1958) 2.63
Studies on phospholipids. I. The determination of amino nitrogen in unhydrolysed phospholipids. Biochem J (1957) 2.17
The phospholipids of ox spleen with special reference to the fatty acid and fatty aldehyde compositions of the lecithin and kephalin fractions. Biochem J (1960) 1.67
The phospholipids of the erythrocyte 'ghosts' of various species. Biochem J (1960) 1.44
THE PHOSPHOLIPIDS OF THE HOUSEFLY, MUSCA DOMESTICA. Biochem J (1963) 1.43
Lipids of Acanthamoeba castellanii. Composition and effects of phagocytosis on incorporation of radioactive precursors. J Cell Biol (1969) 1.25
THE MAGNESIUM-ION-DEPENDENT CLEAVAGE OF THE VINYL ETHER LINKAGE OF BRAIN ETHANOLAMINE PLASMALOGEN. Biochem J (1965) 1.17
The lipid composition of tumour cells. Biochem J (1963) 1.15
Chromatographic separation of brain lipids. 2. Ethanolamine-containing phospholipids. Biochem J (1961) 1.10
Composition of phospholipids of rabbit, pigeon and trout muscle and various pig tissues. Biochem J (1961) 1.06
Enzymatic and nonezymatic alterations of erythrocyte surface antigens. Bacteriol Rev (1963) 1.04
Analysis of lipids from fresh and preserved adult human brains. Biochem J (1962) 1.02
Thromboplastic factors in platelets and red blood cells: observations on their chemical nature and function in vitro coagulation. J Clin Invest (1960) 1.01
Studies on phospholipids. 4. Determination of ethanolamine and serine. Biochem J (1958) 1.00
Chromatographic separation of brain lipids. 3. Serine-containing phospholipids. Biochem J (1962) 0.98
The oxidation of lysine and oxalysine by Mytilus edulis: Identification of the products formed in the presence and the absence of catalase. Biochem J (1967) 0.95
The preparation and properties of lysophosphatidylserine. Biochem J (1962) 0.91
The mechanism of fructose formation in goat placenta with special reference to the possible involvement of sorbitol or of phosphoric acid esters. Biochem J (1961) 0.87
Cardiovascular lesions and changes in blood coagulation and fibrinolysis associated with diet-induced lipemia in the rat. J Clin Invest (1962) 0.84
Lipid-bound amino acids in broad-bean leaves. Biochem J (1964) 0.80
Schiff bases formed from retinal and phosphatidylethanolamine, phosphatidylserine, ethanolamine or serine. Biochem J (1969) 0.76
The phospholipid composition of embryonic chick liver microsomes. Biochem J (1967) 0.75
Some observations on the chromatographic behaviour of phosphatidylserine. Biochem J (1962) 0.75
The role of the plasmalogen in the cross-reaction between group A streptococcus and human myocardium. Br J Exp Pathol (1977) 0.75
A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27
The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74
Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem (1954) 5.08
Identification and assay of serotonin in brain. J Pharmacol Exp Ther (1956) 4.17
Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem (1958) 4.16
The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99
The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther (1961) 3.63
A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. Biochem Pharmacol (1963) 3.62
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60
A chemical method for the determination of free choline in plasma. J Biol Chem (1953) 3.57
Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med (1960) 3.26
On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16
Enzymatic formation of uridine diphosphoglucuronic acid. J Biol Chem (1957) 3.15
Some physico-chemical factors in drug action. J Pharm Pharmacol (1957) 3.13
Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature (1960) 3.07
The fate of antipyrine in man. J Pharmacol Exp Ther (1950) 3.05
Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03
The physiological disposition of H3-epinephrine and its metabolite metanephrine. J Pharmacol Exp Ther (1959) 2.91
Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther (1961) 2.90
Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78
INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther (1965) 2.77
A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71
An experience with group practice; the Montefiore Medical Group, 1948-1956. N Engl J Med (1957) 2.65
Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther (1958) 2.62
Congenital jaundice in rats, due to a defect in glucuronide formation. J Clin Invest (1958) 2.58
The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther (1950) 2.54
The distribution and properties of a histamine-methylating enzyme. J Biol Chem (1959) 2.52
Fate of tritiated noradrenaline at the sympathetic nerve-endings. Nature (1961) 2.50
Purification and properties of phenylethanolamine-N-methyl transferase. J Biol Chem (1962) 2.49
Localizing tritiated norepinephrine in sympathetic axons by electron microscopic autoradiography. Science (1962) 2.46
The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther (1957) 2.46
The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.44
The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38
Enzymatic metabolism of drugs and other foreign compounds. Annu Rev Biochem (1958) 2.36
Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26
Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science (1961) 2.23
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
Detoxication of drugs and other foreign compounds by liver microsomes. Science (1955) 2.20
Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine. J Pharmacol Exp Ther (1959) 2.18
Estimation of intracellular water in man. Am J Physiol (1950) 2.14
FATE OF H3-NORADRENALINE IN SKELETAL MUSCLE BEFORE AND FOLLOWING SYMPATHETIC STIMULATION. Am J Physiol (1963) 2.14
Lack of uptake of catecholamines after chronic denervation of sympathetic nerves. Nature (1961) 2.13
Evidence that serotonin has a role in brain function. Science (1955) 2.13
Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther (1960) 2.10
The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1950) 2.10
Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother (1962) 2.05
INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. Nature (1964) 2.03
Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99
The enzymic cleavage of aromatic ethers. Biochem J (1956) 1.96
[Not Available]. Science (1957) 1.90
A biochemical lesion in congenital, nonobstructive, non-haemolytic jaundice. Nature (1957) 1.88
Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86
Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther (1957) 1.85
Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate. J Pharmacol Exp Ther (1954) 1.78
Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77
The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76
SUBCELLULAR LOCALIZATION OF CATECHOLAMINES IN TISSUES OF THE RAT. J Pharmacol Exp Ther (1963) 1.76
CONTROL OF HYDROXYINDOLE O-METHYLTRANSFERASE ACTIVITY IN THE RAT PINEAL GLAND BY ENVIRONMENTAL LIGHTING. J Biol Chem (1965) 1.71
Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. J Pharmacol Exp Ther (1954) 1.70
The enzymatic N-demethylation of narcotic drugs. J Pharmacol Exp Ther (1956) 1.68
The enzymatic formation of bilirubin glucuronide. Arch Biochem Biophys (1957) 1.67
MELATONIN SYNTHESIS IN THE PINEAL GLAND: EFFECT OF LIGHT MEDIATED BY THE SYMPATHETIC NERVOUS SYSTEM. Science (1964) 1.67
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63
The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62
O-Methylation of catechol amines in vivo. J Biol Chem (1958) 1.61
On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther (1956) 1.61
Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. J Pharmacol Exp Ther (1956) 1.59
The enzymatic metabolism of hexobarbital (evipal). J Pharmacol Exp Ther (1955) 1.56
On the mechanism of tachyphylaxis to tyramine in the isolated rat heart. Br J Pharmacol Chemother (1962) 1.55
Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science (1957) 1.54
METABOLISM OF (H3)NOREPINEPHRINE IN THE RAT BRAIN. J Neurochem (1965) 1.54
Purification and properties of hydroxyindole-O-methyl transferase. J Biol Chem (1961) 1.54
Total body water in man. Am J Physiol (1950) 1.50
Inhibitory effects of beta-diethylaminoethyl diphenylpropylacetate on a variety of drug metabolic pathways in vitro. J Pharmacol Exp Ther (1954) 1.49
Actions of cocaine and tyramine on the uptake and release of H3-norepinephrine in the heart. Biochem Pharmacol (1961) 1.49
The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther (1960) 1.47
PROPERTIES OF NOREPINEPHRINE STORAGE PARTICLES OF THE RAT HEART. J Pharmacol Exp Ther (1963) 1.46
The metabolic fate of H3-epinephrine and C14-metanephrine in the rat. J Biol Chem (1961) 1.45
RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE. Circulation (1963) 1.44
Metabolism of epinephrine and other sympathomimetic amines. Physiol Rev (1959) 1.42
On the mechanism of antidepressant action of imipraminelike drugs. Ann N Y Acad Sci (1962) 1.42
Blood-brain barrier for adrenaline. Science (1959) 1.42
The use of procaine amide in cardiac arrhythmias. Circulation (1951) 1.42
Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). J Pharmacol Exp Ther (1960) 1.41
Pathways of drug metabolism. J Pharm Pharmacol (1956) 1.41
O-Methylation, the principal route of metabolism of epinephrine in man. Science (1958) 1.41
The mechanism of serotonin and catecholamine uptake by platelets. J Pharmacol Exp Ther (1959) 1.40
Role of brain serotonin in reserpine action. Ann N Y Acad Sci (1957) 1.40
Structural requirements for bretylium and guanethidine-like activity. Life Sci (1962) 1.39
Release of serotonin from blood platelets by reserpine in vitro. J Pharmacol Exp Ther (1957) 1.39